ID

23891

Description

Study part: Adverse Events- Post- Vaccination Observation Booster Dose. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381

Mots-clés

  1. 16/07/2017 16/07/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

16 juillet 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Adverse Events- Post- Vaccination Observation Booster Dose Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381

Adverse Events- Post- Vaccination Observation Booster Dose

ADVERSE EVENTS – POST–VACCINATION OBSERVATION
Description

ADVERSE EVENTS – POST–VACCINATION OBSERVATION

Alias
UMLS CUI-1
C0877248
Subject number
Description

Subject number

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
Description

Adverse Events

Type de données

text

Alias
UMLS CUI [1]
C0877248

Similar models

Adverse Events- Post- Vaccination Observation Booster Dose

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
ADVERSE EVENTS – POST–VACCINATION OBSERVATION
C0877248 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Item
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
text
C0877248 (UMLS CUI [1])
Code List
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
CL Item
Information not retrievable [U (Information not retrievable [U)
CL Item
No Vaccine administered [NA (No Vaccine administered [NA)
CL Item
No [N (No [N)
CL Item
Yes, fill in the Non-Serious Adverse Event pages or Serious Adverse Event form [Y (Yes, fill in the Non-Serious Adverse Event pages or Serious Adverse Event form [Y)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial